(Q40650204)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

title

Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

Radosław Chaber

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

author name string

A Raciborska

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

K Bilska

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

E Michalak

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M Pogorzała

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

K Połczyńska

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

G Sobol

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M Wieczorek

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

K Muszyńska-Rosłan

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M Rychlowska-Pruszyńska

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

C Rodriguez-Galindo

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

M Dziuk

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

publication date

7 August 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

Clinical and Translational Oncology

21 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

page(s)

189-195

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s12094-015-1351-6

21 February 2020

exact match

0 references

cites work

Analysis of prognostic factors in ewing sarcoma family of tumors: review of St. Jude Children's Research Hospital studies

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Primary disseminated multifocal Ewing sarcoma: results of the Euro-EWING 99 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Prognostic factors for local and distant control in Ewing sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Outcome after relapse in an unselected cohort of children and adolescents with Ewing sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Safety assessment of intensive induction with vincristine, ifosfamide, doxorubicin, and etoposide (VIDE) in the treatment of Ewing tumors in the EURO-E.W.I.N.G. 99 clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Results of the EICESS-92 Study: two randomized trials of Ewing's sarcoma treatment--cyclophosphamide compared with ifosfamide in standard-risk patients and assessment of benefit of etoposide added to standard treatment in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Prognostic factors for patients with Ewing sarcoma (EWS) at first recurrence following multi-modality therapy: A report from the Children's Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Outcomes and prognostic factors for Ewing-family tumors of the extremities

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Diagnostic accuracy of ¹⁸F-FDG-PET and PET/CT in patients with Ewing sarcoma family tumours: a systematic review and a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Significant benefit of multimodal imaging: PET/CT compared with PET alone in staging and follow-up of patients with Ewing tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Impact of whole-body MRI and FDG-PET on staging and assessment of therapy response in a patient with Ewing sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

An evaluation of [F-18]-fluorodeoxy-D-glucose positron emission tomography, bone scan, and bone marrow aspiration/biopsy as staging investigations in Ewing sarcoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Positron emission tomography for staging of pediatric sarcoma patients: results of a prospective multicenter trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Impact of FDG PET for staging of Ewing sarcomas and primitive neuroectodermal tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Diagnostic accuracy of 18F-FDG PET/CT for detecting recurrence in patients with primary skeletal Ewing sarcoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Ewing's tumors over the age of 40: a retrospective analysis of 47 patients treated according to the International Clinical Trials EICESS 92 and EURO-E.W.I.N.G. 99.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Guidelines for 18F-FDG PET and PET-CT imaging in paediatric oncology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

[18F]Fluorodeoxyglucose positron emission tomography predicts outcome for Ewing sarcoma family of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Imaging of malignant tumours of the long bones in children: monitoring response to neoadjuvant chemotherapy and preoperative assessment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

18F-FDG PET and PET/CT for detection of pulmonary metastases from musculoskeletal sarcomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12094-015-1351-6

Survival after recurrence of Ewing tumors: the St Jude Children's Research Hospital experience, 1979-1999

21 January 2018

1 reference

12 December 2020

FDG-PET for detection of osseous metastases from malignant primary bone tumours: comparison with bone scintigraphy

1 reference

12 December 2020

Evaluation of chemotherapy response in primary bone tumors with F-18 FDG positron emission tomography compared with histologically assessed tumor necrosis

1 reference

12 December 2020

Potential role of FDG PET imaging in predicting metastatic potential and assessment of therapeutic response to neoadjuvant chemotherapy in Ewing sarcoma family of tumors

1 reference

12 December 2020

Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group

1 reference

12 December 2020

FDG PET imaging of childhood sarcomas

1 reference

12 December 2020

10.1007/S12094-015-1351-6

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:26250765%20AND%20SRC:MED&resulttype=core&format=json

21 February 2020

1 reference